COST-EFFECTIVENESS OF DESVENLAFAXINE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN BREAST CANCER PATIENTS IN MEXICO

被引:0
|
作者
Ramirez-Ramirez, M. A. [1 ]
Peniche-Otero, G. [1 ]
Mould-Quevedo, J. F. [2 ]
Nuno-Langre, C. [1 ]
Mucino-Ortega, E.
Galindo-Suarez, R. M. [3 ]
机构
[1] SA CV, CPP Customized Premium Prod, Mexico City, DF, Mexico
[2] Pfizer, New York, NY USA
[3] Pfizer, Mexico City, DF, Mexico
关键词
D O I
10.1016/j.jval.2011.02.601
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A108 / A108
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of breast cancer screening policies in Mexico
    Valencia-Mendoza, Atanacio
    Sanchez-Gonzalez, Gilberto
    Bautista-Arredondo, Sergio
    Torres-Mejia, Gabriela
    Bertozzi, Stefano M.
    [J]. SALUD PUBLICA DE MEXICO, 2009, 51 : S296 - S304
  • [2] COST-EFFECTIVENESS OF CONJUGATED ESTROGENS/BAZEDOXIFENE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN THE UNITED STATES
    Teitsson, S.
    Bobula, J.
    Hawes, C.
    Moffatt, M.
    Ohna, A.
    Borgstrom, F.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A736 - A736
  • [3] COST-EFFECTIVENESS OF BREAST-CANCER-TREATMENT
    STOLL, BA
    [J]. MASTOLOGY 88, 1988, 792 : 45 - 49
  • [4] Desvenlafaxine succinate is effective in the treatment of menopausal vasomotor symptoms
    Archer, David F.
    DuPont, Caroline
    Olivier, Sophie
    Pickar, James
    Constantine, Ginger
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 76S - 77S
  • [5] Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
    Umland, Elena M.
    Falconieri, Laura
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2012, 4 : 305 - 319
  • [6] Economic and cost-effectiveness issues in breast cancer treatment
    Hillner, BE
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (01) : 98 - 104
  • [7] Treatment of vasomotor symptoms in patients with breast cancer, a narrative review
    Pilnik, Susana
    Gelin, Marina
    De Nardo, Barbara
    Alejandra Belardo, Maria
    [J]. REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2018, 64 (01): : 69 - 76
  • [8] Cost-Effectiveness of the 21-Gene Breast Cancer Assay in Mexico
    Juan Enrique Bargalló-Rocha
    Fernando Lara-Medina
    Victor Pérez-Sánchez
    Rafael Vázquez-Romo
    Cynthia Villarreal-Garza
    Hector Martínez-Said
    Robin J. Shaw-Dulin
    Alejandro Mohar-Betancourt
    Barnaby Hunt
    Juliette Plun-Favreau
    William J. Valentine
    [J]. Advances in Therapy, 2015, 32 : 239 - 253
  • [9] Cost-Effectiveness of the 21-Gene Breast Cancer Assay in Mexico
    Bargallo-Rocha, Juan Enrique
    Lara-Medina, Fernando
    Perez-Sanchez, Victor
    Vazquez-Romo, Rafael
    Villarreal-Garza, Cynthia
    Martinez-Said, Hector
    Shaw-Dulin, Robin J.
    Mohar-Betancourt, Alejandro
    Hunt, Barnaby
    Plun-Favreau, Juliette
    Valentine, William J.
    [J]. ADVANCES IN THERAPY, 2015, 32 (03) : 239 - 253
  • [10] COST-EFFECTIVENESS OF TRASTUZUMAB In the Treatment of Early Stages Breast Cancer Patients, in Portugal
    Macedo, Ana
    Monteiro, Isabel
    Andrade, Sofia
    Cirrincione, A.
    Ray, J.
    [J]. ACTA MEDICA PORTUGUESA, 2010, 23 (03): : 475 - 482